English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
腾讯网
1 个月
丽珠集团:注射用JP-1366获批开展临床试验,国内尚无P-CAB注射剂申报 ...
丽珠集团公告:近日,丽珠医药集团股份有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,批准注射用JP-1366开展临床试验。
第一财经
1 个月
分享到微信
18:12【健康元:获得注射用JP-1366临床试验批准通知书】健康元公告,控股子公司丽珠医药集团股份有限公司收到国家药品监督管理局核准签发的 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Sworn in as Canada's PM
Legendary sportswriter dies
Man hit by motorcade, dies
Strikes deal with DOGE
US influencer sparks outrage
Ordered to reinstate workers
March megastorm
To host Golden Globes
Top intelligence agency visit
Smishing scam warning
Khalil sues Columbia
To cut 2,000+ jobs
Won't block GOP bill
Trump Tower protest
Ditch new stadium deal
Top FDA lawyer resigns
FDA, NIH nominees advance
Swatting call about gunman
Teixeira pleads guilty
Plane engine catches fire
$3B deal to extend rights
IRS demotes chief counsel
Hamas to release hostage
‘Ted Lasso’ is coming back
UN report accuses Israel
Exits bankruptcy protection
Senate confirmation hearing
Influential WY senator dies
Texas Tech closes campus
CDC nomination withdrawn
Out as creative director
反馈